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background:  Exercise training can improve functional capacity in patients with heart failure (HF), but the response is heterogeneous. 
Change in peak oxygen consumption (peak VO2) after an exercise program is related to survival in this population. We sought to 
investigate if there are any differences in biomarker serum levels among patients with HF who respond to exercise training in comparison 
to those who do not respond.
Methods:  This is a sub-study of “Interval training versus continuous training on sympathetic activity and peripheral perfusion in patients 
with HF: randomized study with control group.” Forty patients with diagnosis of HF, left ventricle ejection fraction (LVEF) ≤ 0,40, under 
optimized clinical treatment and stable in the previous six weeks were randomized into three groups: interval exercise (group I), continuous 
exercise (group II) and control group (group III). Serum levels of adiponectin, galectin-3, interleukin-6 (IL-6) and tumor necrosis factor alpha 
(TNF-alpha) were measured before and after 12 weeks of aerobic exercise, three sessions per week. For this analysis, only the patients in 
the groups I and II were included and classified as responders if they achieved a 6% increase in percentage predicted peak VO2 measured 
by a treadmill cardiopulmonary exercise testing (CPET).
Results:  Twenty six patients, 51±7 years old, 53% men, LVEF 30±6%, 31% ischemic were included in the analysis (responders - 12, non-
responders - 14). At baseline, the CPET exercise time, (8.9 ± 1.8 vs 11.4 ± 1.8 min, p=0.001), the VO2/work-rate relationship [9.7 (9.5-11.3) 
vs 11.5 (10.2-12.5) mL.min-1.W-1, p=0.041], the galectin-3 levels [1.0 (0.3-2.0) vs 3.2 (1.6-6.7) pg/mL, p=0.015] and the IL-6 levels (5.3 ± 
1.9 vs 7.2 ± 1.8 ng/mL, p=0.015) were lower among the responders than the non-responders patients, respectively.
conclusion:  We have found that galectin-3 and IL-6 levels arelower among the patients with HF who respond to 12 weeks exercise 
training than those who do not respond.
